The FDA establishes rigorous microbiological and chemical standards for high-purity water systems used in pharmaceutical manufacturing. These standards are fundamental to ensuring the safety, efficacy, and sterility of drug products, regardless of whether they are produced domestically or internationally. Water…
Horizant (gabapentin enacarbil) is an FDA-approved extended-release medication used to treat two serious neurological conditions: moderate-to-severe restless legs syndrome (RLS) and postherpetic neuralgia (PHN)—the debilitating nerve pain that follows shingles infection. Unlike standard gabapentin which requires three daily doses, Horizant…
Melasma, commonly known as the “mask of pregnancy,” affects 36.4% to 75% of pregnant women and causes significant emotional distress due to brown or gray patches on the face. Tinto-MH cream, represents a scientifically-proven triple combination therapy specifically approved by…
Have you ever wondered why some anticold tablets work better for productive cough while others excel at relieving nasal congestion? The answer lies in their formulation strategy. Laricold Tablet represents a comprehensive approach to cold management, combining five active pharmaceutical…
FTOX-AM syrup is a fixed-dose combination (FDC) containing ambroxol hydrochloride (15 mg), terbutaline sulfate (1.25 mg), guaiphenesin (50 mg), and menthol (2.5 mg) per 5 mL. This comprehensive guide provides evidence-based information on its clinical efficacy, mechanisms of action, proper…
Paediatric guide · India · Updated 2026 Cough Syrup for Children in India (2026): The Age Rules, and What to Do Instead There is no “best paediatric cough syrup” to name any more, and below five years the question is…
Formulation guide · India · Updated August 2026 Short answer: since 9 June 2026 there is no “best dry cough syrup you can buy” in India, because you can no longer buy one off the shelf. Notification G.S.R. 477(E) deleted…
The Indian pharmaceutical industry, currently valued at over $50 billion and targeting $130 billion by 2030, stands at a pivotal technological crossroads in the fiscal years 2025-2026. As the global leader in generic drug manufacturing and a burgeoning hub for…
MYQORZO (aficamten) represents a significant advancement in the management of obstructive hypertrophic cardiomyopathy (oHCM), a condition characterized by thickened heart muscle that obstructs blood flow out of the heart. Approved by the FDA in December 2025, it provides a targeted…
Short answer: what a pharma plant costs in India in 2026 The pharma manufacturing plant cost in India runs from roughly ₹5–15 crore for a small oral-solids unit, ₹50–80 crore for a mid-scale multi-formulation export-capable facility, and ₹170–355 crore for…